Update on Biomarkers to Predict Responders to Allergen Immunotherapy

Philippe Moingeon
Current Treatment Options in Allergy 4 ( 1) 30 -42

2017
Identification of a New Phenotype of Tolerogenic Human Dendritic Cells Induced by Fungal Proteases from Aspergillus oryzae

Aline Zimmer , Sonia Luce , Fanny Gaignier , Emmanuel Nony
Journal of Immunology 186 ( 7) 3966 -3976

16
2011
CD2-mediated adhesion facilitates T lymphocyte antigen recognition function.

Philippe Moingeon , Hsiu-Ching Chang , Barbara P. Wallner , Christopher Stebbins
Nature 339 ( 6222) 312 -314

263
1989
PD01 - Respiratory allergens in human milk: potential impact on susceptibility to allergic airway disease

Patricia Macchiaverni , Akila Rekima , Mathilde Turfkruyer , Laurent Mascarell
Clinical and Translational Allergy 4 ( 1) 1 -1

4
2014
Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53.

Laurence Odin , Marie Favrot , Dominique Poujol , Jean-Philippe Michot
Cancer Gene Therapy 8 ( 2) 87 -98

18
2001
Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients.

Anand G Menon , Peter J K Kuppen , Sjoerd H van der Burg , Rienk Offringa
Cancer Gene Therapy 10 ( 7) 509 -517

41
2003
Glycoproteins are species-specific markers and major IgE reactants in grass pollens

Hélène Manduzio , Anne-Catherine Fitchette , Maud Hrabina , Henri Chabre
Plant Biotechnology Journal 10 ( 2) 184 -194

12
2012
Suspension-cultured BY-2 tobacco cells produce and mature immunologically active house dust mite allergens.

David Lienard , Olivia Tran Dinh , Erika van Oort , Laurence Van Overtvelt
Plant Biotechnology Journal 5 ( 1) 93 -108

36
2007
Multiple-allergen And Single-allergen Immunotherapy Strategies In Polysensitized Patients: Looking At The Published Evidence

Moisés A. Calderón , Linda Cox , Thomas B. Casale , Philippe Moingeon
The Journal of Allergy and Clinical Immunology 129 ( 4) 929 -934

131
2012
A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapy.

Aline Zimmer , Julien Bouley , Maxime Le Mignon , Elodie Pliquet
The Journal of Allergy and Clinical Immunology 129 ( 4) 1020 -1030

114
2012
Identification Of The Cysteine Protease Amb a x As A Novel Major Allergen From Short Ragweed Pollen (Ambrosia artemisiifolia)

Philippe Moingeon , Julien Bouley , Maxime Le Mignon , Véronique Baron-Bodo
Journal of Allergy and Clinical Immunology 133 ( 2) AB101

1
2014
Interest Of Mass Spectrometry-Based Quantification Of Relevant Allergens To Improve The Standardization Of Allergen Extracts

Thierry Batard , Emmanuel Nony , Christel Dayang , Julien Bouley
The Journal of Allergy and Clinical Immunology 133 ( 2)

2
2014
Molecular Differences in Major and Minor Allergens From US Grass Species Support the Association of Several Pollens for Specific Immunotherapy

Thierry Batard , Henri Chabre , Véronique Baron-Bodo , Emmanuel Nony
Journal of Allergy and Clinical Immunology 131 ( 2) AB38

2013
CCR10+ ILC2s with ILC1‐like properties exhibit a protective function in severe allergic asthma

Chloé Beuraud , Vincent Lombardi , Sonia Luce , Stéphane Horiot
Allergy 74 ( 5) 933 -943

10
2019
IL-10 mRNA levels in whole blood cells correlate with house dust mite allergen immunotherapy efficacy.

Claire Guéguen , Sonia Luce , Vincent Lombardi , Véronique Baron‐Bodo
Allergy 74 ( 11) 2223 -2226

9
2019
Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma.

Sophie Tourdot , Sabi Airouche , Nathalie Berjont , Hélène Moussu
Vaccine 31 ( 23) 2628 -2637

22
2013
Recombinant fusion proteins assembling Der p 1 and Der p 2 allergens from Dermatophagoides pteronyssinus.

Laetitia Bussières , Véronique Bordas-Le Floch , Ingrid Bulder , Henri Chabre
International Archives of Allergy and Immunology 153 ( 2) 141 -151

18
2010
Immunological Foundations to the Quest for New Vaccine Adjuvants

Nicolas Burdin , Bruno Guy , Philippe Moingeon
BioDrugs 18 ( 2) 79 -93

46
2004